Baseline | ZES | EES | P value |
(n=30) | (n=30) | ||
Follow-up | (n=24) | (n=22) | |
Procedure | |||
Reference vessel diameter (mm) | 2.18±0.40 | 2.38±0.59 | 0.1343 |
Length of stenosis (mm) | 14.2±5.09 | 14.1±6.41 | 0.9328 |
Area stenosis (%) | 78.59±10.88 | 82.15±13.47 | 0.2647 |
Maximum balloon diameter (mm) | 2.81±0.46 | 2.65±0.52 | 0.2373 |
Poststent insertion stenosis (%) | 14.88±7.04 | 18.03±12.02 | 0.2197 |
Improved stenosis | 65.55±15.00 | 63.48±15.38 | 0.6011 |
Acute loss (mm) | 0.42±0.48 | 0.59±0.45 | 0.1669 |
Follow-up | |||
Area stenosis (%) | 40.83±21.46 | 39.58±21.16 | 0.8415 |
Stent diameter reduction (%) | −5.52±27.65 | −13.05±22.63 | 0.3130 |
Late loss (mm) | 0.06±0.50 | 0.36±0.66 | 0.0833 |
Plus-minus values are mean±SD.
EES, everolimus-eluting stent; n, number; ZES, zotarolimus-eluting stent.